That myopathy was not a major feature was supported by our FGF-21 results: FGF-21 levels were also lower in the group of patients with nuclear gene mutations than it could be expected, but similar to those reported earlier in ataxic POLG patients (Suomalainen et al., 2011). This evidence concerns the gene FGF21 and myopathy.